Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression

Cancer Research

Volumn 63, Issue 3, 2003, Pages 567-572

  Allen, Sarah M ^b   Florell, Scott R ^a   Hanks, Adrianne N ^b   Alexander, April ^a   Diedrich, Miyoung J ^b   Altieri, Dario C ^c   Grossman, Douglas ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; MITOSIS INDEX; MOUSE; NONHUMAN; PAPILLOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR GROWTH;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CARCINOGENS; FEMALE; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PAPILLOMA; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037310396     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Marks, R., Foley, P., Goodman, G., Hage, B. H., and Selwood, T. S. Spontaneous remission of solar keratoses: the case for conservative management. Br. J. Dermatol., 115: 649-655, 1986.
2. Brown, K., and Balmain, A. Transgenic mice and squamous multistage skin carcinogenesis. Cancer Metastasis Rev., 14: 113-124, 1995.
3. Leder, A., Kuo, A., Cardiff, R. D., Sinn, E., and Leder, P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA, 87: 9178-9182, 1990.
4. Spalding, J. W., Momma, J., Elwell, M. R., and Tennant, R. W. Chemically induced skin carcinogenesis in a transgenic mouse line (TG. AC) carrying a v-Ha-ras gene. Carcinogenesis (Lond.), 14: 1335-1341, 1993.
5. Burns, F. J., Vanderlaan, M., Sivak, A., and Albert, R. E.: Regression kinetics of mouse skin papillomas. Cancer Res., 36: 1422-1427, 1976.
6. de Gruijl, F. R., and Forbes, P. D. UV-induced skin cancer in a hairless mouse model. Bioessays, 17: 651-660, 1995.
7. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
8. Leffell, D. J., and Brash, D. E. Sunlight and skin cancer. Sci. Am., 275: 52-59, 1996.
9. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., and Ponten, J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 88: 10124-10128, 1991.
10. Li, G., Tron, V., and Ho, V. Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation. J. Investig. Dermatol., 110: 72-75, 1998.
11. Kemp, C. J., Donehower, L. A., Bradley, A., and Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74: 813-822, 1993.
12. Nelson, M. A., Einspahr, J. G., Alberts, D. S., Balfour. C. A., Wymer, J. A., Welch, K. L., Salasche, S. J., Bangert, J. L., Grogan, T. M., and Bozzo, P. O. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett., 85: 23-29, 1994.
13. Taguchi, M., Watanabe, S., Yashima, K., Murakami, Y., Sekiya, T., and Ikeda, S. Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin. J. Investig. Dermatol., 103: 500-503, 1994.
14. Ambrosini, G., Adida, C., and Altieri, D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med., 3: 917-921, 1997.
15. Deveraux, Q. L., and Reed, J. C.: IAP family proteins-suppressors of apoptosis. Genes Dev., 13: 239-252, 1999.
16. Adams, J. M., and Cory, S.: The Bcl-2 protein family: arbiters of cell survival. Science (Wash. DC), 281: 1322-1326, 1998.
17. , O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa. A., Tognin, S., Marchisio, P. C., and Altieri, D. C. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA, 97: 13103-13107, 2000.
18. Tamm, I., Wang, Y., Sausville, E., Scudiero, D. A., Vigna, N., Oltersdorf, T., and Reed, J. C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res., 58: 5315-5320, 1998.
19. Altieri, D. C., Marchisio, P. C., and Marchisio, C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab. Investig., 79: 1327-1333, 1999.
20. Grossman, D., McNiff, J. M., Li, F., and Altieri, D. C.: Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab. Invest., 79: 1121-1126, 1999.
21. Lo Muzio, L., Staibano, S., Pannone, G., Mignogna, M. D., Mariggio, A., Salvatore, G., Chieffi, P., Tramontano, D., De Rosa, G., and Altieri, D. C. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp. Mol. Pathol., 70: 249-254, 2001.
22. Grossman, D., McNiff, J. M., Li, F., and Altieri, D. C.: Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest., Dermatol., 113: 1076-1081, 1999.
23. Grossman, D., Kim, P. J., Schechner, J. S., and Altieri, D. C.: Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA, 98: 635-640, 2001.
24. Mesri, M., Wall, N. R., Li, J., Kim, R. W., and Altieri, D. C.: Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest., 108: 981-990, 2001.
25. Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., Cook, B. P., Dufault, M. R., Ferguson, A. T., Gao. Y., He, T. C., Hermeking, H., Hiraldo, S. K., Hwang, P. M., Lopez, M. A., Luderer, H. F., Mathews, B., Petroziello, J. M., Polyak, K., Zawel. L., Zhang, W., Zhang, X., Zhou, W. W., Haluska, F. G., Jen, J., Sukumar, S., Landes, G. M., Riggins, G. J., Vogelstein, B., and Kinzler, K. W. Analysis of human transcriptomes. Nat. Genet., 23: 387-388, 1999.
26. Altieri, D. C. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol. Med., 7: 542-547, 2001.
27. Grossman, D., Kim, P. J., Blanc-Brude, O. P., Brash, D. E., Tognin, S., Marchisio, P. C., and Altieri, D. C.: Transgenic expression of survivin in keratinocytes counteracts UVB- induced apoptosis and cooperates with loss of p53. J. Clin. Invest., 108: 991-999, 2001.
28. Imamoto, A., Wang, X. J., Fujiki, H., Walker, S. E., Beltran, L. M., and DiGiovanni, J. Comparison of 12-O-tetradecanoylphorbol-13-acetate and teleocidin for induction of epidermal hyperplasia, activation of epidermal PKC isozymes and skin tumor promotion in SENCAR and C57BL/6 mice. Carcinogenesis (Lond.), 14: 719-724, 1993.
29. Fortugno, P., Wall, N. R., Giodini, A., O'Connor, D. S., Plescia, J., Padgett, K. M., Tognin, S., Marchisio, P. C., and Altieri, D. C. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell Sci., 115: 575-585, 2002.
30. Rodriguez-Villanueva, J., Greenhalgh, D., Wang, X. J., Bundman, D., Cho, S., Delehedde, M., Roop, D., and McDonnell, T. J. Human keratin-1, bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene, 16: 853-863, 1998.
31. Evan, G. I., and Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature (Lond.), 411: 342-348, 2001.
32. Pena, J. C., Rudin, C. M., and Thompson, C. B. A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res., 58: 2111-2116, 1998.
33. Ganguli, G., Abecassis, J., and Wasylyk, B. MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis. EMBO J., 19: 5135-5147, 2000.
34. Alkhalaf, M., Ganguli, G., Messaddeq, N., Le Meur, M., and Wasylyk, B.: MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice. Oncogene, 18: 1419-1434, 1999.
35. Rossiter, H., Beissert, S., Mayer, C., Schon, M. P., Wienrich, B. G., Tschachler, E., and Kupper, T. S. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Cancer Res., 61: 3619-3626, 2001.
36. Vassar, R., and Fuchs, E. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev., 5: 714-727, 1991.
37. Jonason, A. S., Kunala, S., Price, G. J., Restifo, R. J., Spinelli, H. M., Persing, J. A., Leffell, D. J., Tarone, R. E., and Brash, D. E. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA, 93: 14025-14029, 1996.
38. Zhang, W., Remenyik, E., Zelterman, D., Brash, D. E., and Wikonkal, N. M.: Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc. Natl. Acad. Sci. USA, 98: 13948-13953, 2001.
39. Reed, J. C. Mechanisms of apoptosis. Am. J. Pathol., 157: 1415-1430, 2000.
40. Soengas, M. S., Alarcon, R. M., Yoshida. H., Giaccia, A. J., Hakem, R., Mak, T. W., and Lowe, S. W. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (Wash. DC), 284: 156-159, 1999.
41. Schuler, M., Bossy-Wetzel, E., Goldstein, J. C., Fitzgerald, P., and Green, D. R.: p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem., 275: 7337-7342, 2000.
42. Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., and Murphy, M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem., 277: 3247-3257, 2002.